Nosocomial, Healthcare-Associated, and Community-Acquired Acinetobacter baumannii in China: Clinical Characteristics, Antimicrobial Resistance Patterns and Risk Factors Associated with Carbapenem Resistance
Yuqing Li,Jiachen Zhang,Yingjuan Gu,Ling Wang,Jing Hu
DOI: https://doi.org/10.2147/idr.s469244
2024-09-20
Infection and Drug Resistance
Abstract:Yuqing Li, 1, &ast Jiachen Zhang, 2, &ast Yingjuan Gu, 1 Ling Wang, 1 Jing Hu 1 1 Department of Nosocomial Infection Administration, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China; 2 Clinical Research Center, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jing Hu, Department of Nosocomial Infection Administration, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, People's Republic of China, Tel +8620-61643605 ; +8615622316318, Email Background: Acinetobacter baumannii (A. baumannii ) is an widespread pathogen and carbapenem-resistant strains are great threat to hospitalized patients. This study is aimed to investigate the clinical characteristics, antimicrobial resistance patterns, and risk factors associated with carbapenem resistance in nosocomial, healthcare-associated (HCA), and community-acquired (CA) A. baumannii infections. Methods: This study retrospectively reviewed cases in a tertiary hospital in southern China between January 1, 2019, and December 31, 2021. Univariate and multivariate logistic regression analyses were performed to identified the risk factors of carbapenem resistance in nosocomial, HCA and CA A. baumannii infections. Results: A total of 391 patients with A. baumannii infection were included. Of these patients, 96 (24.6%) had nosocomial infections, 215 (55.0%) had HCA infections, and 80 (20.5%) had CA infections. The overall 30-day mortality rates of nosocomial and HCA infection patients was significantly higher than that of CA infection (P< 0.05). The incidence of antimicrobial resistance was also higher in nosocomial and HCA bacteremia than that in CA bacteremia (P< 0.05). Logistic regression analysis identified age ≥ 60 years, urethral catheterization, and exposure to two or more antibiotics as the independent risk factors for carbapenem-resistant A. baumannii (CRAB) infection in the nosocomial infection group and exposure to two or more antibiotics and endotracheal intubation in the HCA infection group. However, malignant tumors and hematological diseases were identified as protective factors against CRAB infection in the HCA group. Conclusion: These data suggest that HCA A. baumannii infection is quite different from CA infection, with antimicrobial resistance and 30-day mortality rates similar to those of nosocomial infections. Additionally, the risk factors for CRAB development in the CA, HCA, and nosocomial groups were not the same, which may provides the help for controlling practices and instruction empirical clinical medication. Keywords: Acinetobacter baumannii , community-acquired, healthcare-associated, nosocomial, antimicrobial resistance, risk factor Acinetobacter baumannii , a nonfermenting gram-negative bacterium, is widespread in hospital and community environments. It can colonize a large variety of surfaces and is able to cause various infections opportunistically. 1,2 These infections are characterized by costly treatment and high mortality rates because an extensive range of infections are caused by multidrug-resistant A. baumannii . 3 Carbapenems are broad-spectrum antibacterial drugs usually recommended for treating serious infections caused by multidrug-resistant A. baumannii . However, with the misuse of antibacterial agents and poor infection control practices, the detection rate of carbapenem-resistant A. baumannii (CRAB) isolates is increasing which has become a global health concern. 1,4 Infections are generally classified into community-acquired (CA) and nosocomial infections based on their origin. In most studies, nosocomial infections are severer than CA infections, and nosocomial infection-associated pathogens have a greater degree of drug resistance. 5 For the past few years, community-onset infections that occur in inpatients who have recently received health care services and undergone medical procedures have received increasing attention. 6–8 This type of infection is separate from CA infection and is referred to as community-onset healthcare-associated (HCA) infection. Several studies have explored this new type of infection. A study from southern China found that HCA infections presented similar clinical features and antimicrobial resistance to nosocomial infections but were distinct from CA infections. 8 Another study in Taiwan showed that HCA infections are quiet different from CA and nosocomial infections in antimicro -Abstract Truncated-
pharmacology & pharmacy,infectious diseases